Jubilant Pharmova Ltd (JUBLPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 525933,
    "name": "Jubilant Pharmo",
    "stock_name": "Jubilant Pharmo",
    "full_name": "Jubilant Pharmova Ltd",
    "name_url": "stocks-analysis/jubilant-pharmo",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "973.15",
    "chg": -19.35,
    "chgp": "-1.95%",
    "dir": -1,
    "prev_price": "992.50",
    "mcapval": "15,662.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530019,
    "symbol": "JUBLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE700A01033",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "83.62 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/jubilant-pharmo-525933-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-3975704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JubilantPharmov_mojoScore_3975704.png",
        "date": "2026-05-05 10:10:53",
        "description": "Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-3960577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_mojoScore_3960577.png",
        "date": "2026-04-24 10:10:43",
        "description": "Jubilant Pharmova Ltd is rated Sell by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Jubilant Pharmova Gains 2.23%: Technical Shift and Financial Challenges Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-gains-223-technical-shift-and-financial-challenges-shape-week-3952618",
        "imagepath": "",
        "date": "2026-04-18 17:03:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Upgrade to Sell rating on technical improvements despite financial pressures</p>\n                    <p><strong>13 Apr:</strong> Technical momentum shifts from strongly bearish to mildly bearish</p>\n                    <p><strong>17 Apr:</strong> Stock closes at Rs.911.60, up 0.72% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.891.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.911.60</div><div class=\"stat-change positive\">+2.23%</div></div>\n       ..."
      },
      {
        "title": "Jubilant Pharmova Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3944133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_mojoScore_3944133.png",
        "date": "2026-04-13 08:05:49",
        "description": "Jubilant Pharmova Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 April 2026, reflecting nuanced shifts across technical indicators and valuation metrics despite ongoing financial challenges. This recalibration follows a detailed analysis of the company’s quality, valuation, financial trends, and technical outlook, providing investors with a clearer perspective on its current market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-technical-momentum-shifts-amid-mixed-market-signals-3943945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_technicaldot_3943945.png",
        "date": "2026-04-13 08:02:02",
        "description": "Jubilant Pharmova Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.26%, the stock’s broader trend signals caution amid mixed signals from MACD, RSI, and moving averages, underscoring the challenges facing this small-cap pharmaceutical player in a volatile market environment."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-strong-sell-3937253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/JubilantPharmov_mojoScore_3937253.png",
        "date": "2026-04-08 10:10:53",
        "description": "Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-strong-sell-3921382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JubilantPharmov_mojoScore_3921382.png",
        "date": "2026-03-28 10:10:27",
        "description": "Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd Surges 7.07% to Day's High of Rs 874.55 — Outperforms Sector by 6.15 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-hits-intraday-high-with-707-surge-on-24-mar-2026-3910555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/JubilantPharmov_priceRelatedfactors_3910555.png",
        "date": "2026-03-24 13:00:50",
        "description": "The Sensex gained 2.05% on 24 Mar 2026, yet Jubilant Pharmova Ltd outpaced the broader market with a 7.07% surge, reaching an intraday high of Rs 874.55. This 6.15 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market lift."
      }
    ],
    "total": 15,
    "sid": "525933",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/jubilant-pharmova-525933"
  },
  "announcements": [
    {
      "caption": "USFDA Inspection Update - Contract Manufacturing Facility At Montreal Canada",
      "datetime": "29-May-2026",
      "details": "USFDA update",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-May-2026",
      "details": "Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "22-May-2026",
      "details": "Change in CFO",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06",
          "dt": "2006-03-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jubilant Pharmova Ltd is Rated Sell

2026-05-05 10:10:53

Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and technical outlook.

Jubilant Pharmova Ltd is Rated Sell

2026-04-24 10:10:43

Jubilant Pharmova Ltd is rated Sell by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Jubilant Pharmova Gains 2.23%: Technical Shift and Financial Challenges Shape Week

2026-04-18 17:03:07

Key Events This Week 13 Apr: Upgrade to Sell rating on technical improvements despite financial pressures 13 Apr: Technical momentum shifts from strongly bearish to mildly bearish 17 Apr: Stock closes at Rs.911.60, up 0.72% on the day Week OpenRs.891.75 Week CloseRs.911.60+2.23% ...

Jubilant Pharmova Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-04-13 08:05:49

Jubilant Pharmova Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 10 April 2026, reflecting nuanced shifts across technical indicators and valuation metrics despite ongoing financial challenges. This recalibration follows a detailed analysis of the company’s quality, valuation, financial trends, and technical outlook, providing investors with a clearer perspective on its current market positioning within the Pharmaceuticals & Biotechnology sector.

Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-13 08:02:02

Jubilant Pharmova Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 1.26%, the stock’s broader trend signals caution amid mixed signals from MACD, RSI, and moving averages, underscoring the challenges facing this small-cap pharmaceutical player in a volatile market environment.

Jubilant Pharmova Ltd is Rated Strong Sell

2026-04-08 10:10:53

Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Jubilant Pharmova Ltd is Rated Strong Sell

2026-03-28 10:10:27

Jubilant Pharmova Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Jubilant Pharmova Ltd Surges 7.07% to Day's High of Rs 874.55 — Outperforms Sector by 6.15 Percentage Points

2026-03-24 13:00:50

The Sensex gained 2.05% on 24 Mar 2026, yet Jubilant Pharmova Ltd outpaced the broader market with a 7.07% surge, reaching an intraday high of Rs 874.55. This 6.15 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market lift.

View All News